Created at	Source	Raw Value	Validated value
Oct. 14, 2021, 2:24 p.m.	usa	GMT of subject's anti- SARS-CoV-2 neutralizing antibody;GMT of subject's anti- SARS-CoV-2 neutralizing antibody;Rate of 4-fold rise of anti- SARS-CoV-2 neutralizing antibody;Rate of 4-fold rise of anti- SARS-CoV-2 neutralizing antibody;The incidence and serverity of any adverse reactions;The incidence and serverity of solicited adverse events;The incidence and serverity of solicited adverse events;The incidence and serverity of solicited adverse reactions;The incidence and serverity of solicited adverse reactions;The incidence and severity of unsolicited adverse reactions;The incidence of AESI observed;The incidence of SAE observed	GMT of subject's anti- SARS-CoV-2 neutralizing antibody;GMT of subject's anti- SARS-CoV-2 neutralizing antibody;Rate of 4-fold rise of anti- SARS-CoV-2 neutralizing antibody;Rate of 4-fold rise of anti- SARS-CoV-2 neutralizing antibody;The incidence and serverity of any adverse reactions;The incidence and serverity of solicited adverse events;The incidence and serverity of solicited adverse events;The incidence and serverity of solicited adverse reactions;The incidence and serverity of solicited adverse reactions;The incidence and severity of unsolicited adverse reactions;The incidence of AESI observed;The incidence of SAE observed
Oct. 7, 2021, noon	usa	4-fold rise of anti- SARS-CoV-2 neutralizing antibody;4-fold rise of anti- SARS-CoV-2 neutralizing antibody;GMT of anti- SARS-CoV-2 neutralizing antibody;GMT of anti- SARS-CoV-2 neutralizing antibody;The incidence and serverity of any adverse reactions;The incidence and serverity of solicited adverse events;The incidence and serverity of solicited adverse events;The incidence and serverity of solicited adverse reactions;The incidence and serverity of solicited adverse reactions;The incidence and severity of unsolicited adverse reactions;The incidence of AESI observed;The incidence of SAE observed	4-fold rise of anti- SARS-CoV-2 neutralizing antibody;4-fold rise of anti- SARS-CoV-2 neutralizing antibody;GMT of anti- SARS-CoV-2 neutralizing antibody;GMT of anti- SARS-CoV-2 neutralizing antibody;The incidence and serverity of any adverse reactions;The incidence and serverity of solicited adverse events;The incidence and serverity of solicited adverse events;The incidence and serverity of solicited adverse reactions;The incidence and serverity of solicited adverse reactions;The incidence and severity of unsolicited adverse reactions;The incidence of AESI observed;The incidence of SAE observed